NDC 80425-0033-06 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0033
- Requested NDC
- 80425-0033-06
- Package NDCs from labels
- 80425-0033-4, 80425-0033-1, 80425-0033-2, 80425-0033-3, 80425-0033-5, 80425-0033-6, 80425-0033-06
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2026-03-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0033-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 12 | |
| 80425-0033-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 12 | |
| 80425-0033-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 12 | |
| 80425-0033-4 | Gabapentin | 40 in 1 BOTTLE | CAPSULE | 40 | 12 | |
| 80425-0033-5 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 12 | |
| 80425-0033-6 | Gabapentin | 9 in 1 BOTTLE | CAPSULE | 9 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0033 | GABAPENTIN CAPSULE [ADVANCED RX OF TENNESSEE, LLC] | 10 | Current NDC, Legacy NDC, 6 package rows | 20250221_afc83432-8fce-6d2a-e053-2a95a90ae73f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0033-1 | EA - Each | 80425-0033 | 9436a3ad-de85-4153-a6c1-1bc48a0c0ea9 | 1 | 2023-06-06 |
| 80425-0033-2 | EA - Each | 80425-0033 | f1d09a02-72a4-486f-a426-6c8d6d9fd956 | 1 | 2023-06-06 |
| 80425-0033-3 | EA - Each | 80425-0033 | 98f4b8be-49fb-4eaa-b05b-544343fd0e05 | 1 | 2023-06-06 |
| 80425-0033-4 | EA - Each | 80425-0033 | a3084993-3234-4a78-b106-1d887c7721c4 | 1 | 2023-06-06 |
| 80425-0033-5 | EA - Each | 80425-0033 | 869fe2d3-45a1-4521-b1b8-9b0a28976912 | 1 | 2025-03-04 |
| 80425-0033-6 | EA - Each | 80425-0033 | 2cb2f884-e0fb-4a65-b21b-67d983685b75 | 1 | 2026-04-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 1b44a3ab-4d06-205f-e063-6294a90af368 | 2026-06-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54dc347e-cba0-ea73-e063-6294a90ab436 | 2026-06-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 235a6954-318a-9e3a-e063-6394a90a0e21 | 2026-06-19 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c9f0cceb-b24e-4526-b873-fedd877d6bc6 | 2026-06-18 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Granules Pharmaceuticals Inc | c681c804-c6f3-d63b-e053-2995a90a6b8f | 2026-06-17 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9a829dc3-b2d8-4d19-a579-0597217cec9b | 2026-06-17 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b7a29b99-ce23-950e-e053-2995a90a1934 | 2026-06-09 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 5385e27c-f2fa-32d5-e063-6294a90a0a8c | 2026-06-05 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 07f07d15-ee91-8c2a-e063-6394a90a4624 | 2026-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | b2da7d96-73ad-4f44-8784-160a384a0961 | 2026-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | f93eaa4f-cc1a-10ab-e053-6394a90a5ffc | 2026-06-02 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Direct_Rx | f8998c1c-c359-6f01-e053-6294a90aebf4 | 2026-06-01 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| gabapentin | GABAPENTIN | Proficient Rx LP | c7674ea5-276b-4bb3-821b-4ac05c9e64e6 | 2026-06-01 | Warnings, Adverse reactions | 310432 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amneal Pharmaceuticals LLC | 507bf6d0-e7a2-413d-9848-cd2445a1411d | 2026-05-30 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Laurus Labs Limited | 07aa1bcc-df05-44fa-92d4-63894e0e6cd6 | 2026-05-28 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 03031adf-d36b-45ec-944e-dfce5a5de91a | 2026-05-28 | Warnings, Adverse reactions | ANDA090858 310430 310432 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Pangea Pharmaceuticals, LLC | 5eff7ad8-0d31-4372-82a2-ac9f549d8796 | 2026-05-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 397fd6d3-317b-4b61-a52b-3a09ca1d88a4 | 2026-05-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | 13640281-26b4-402e-8f69-7c81cd6e0376 | 2026-05-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Amici Pharma, Inc. | 1ea83c18-7107-41f4-8305-62725c1c45c8 | 2026-05-19 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.